Could a simple drug make thyroid surgery recovery smoother?

NCT ID NCT07462195

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving a drug called dexmedetomidine during thyroid surgery helps patients wake up more smoothly. The drug aims to reduce coughing, agitation, and the amount of anesthesia needed. About 100 adults having thyroid surgery will be randomly assigned to receive either the drug or standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dexmedetomidine

What this could lead to

If it works, this could lead to a smoother, safer recovery after thyroid surgery with less coughing and fewer complications.

What could go wrong

This is a small, early-phase trial focused on short-term outcomes. The drug may not significantly improve recovery or could cause side effects like slow heart rate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYROID DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergence Delirium Postoperative Nausea and Vomiting thyroid gland disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Center for Anesthesia and Surgical Intensive Care, Bach Mai Hospital

    RECRUITING

    Hanoi, Vietnam

    Contact Phone: •••-•••-•••• Email: •••••@•••••